146 related articles for article (PubMed ID: 38321350)
1. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
[TBL] [Abstract][Full Text] [Related]
2. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
3. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
4. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
[TBL] [Abstract][Full Text] [Related]
5. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
Wang H; Cao H; Cao J; Zhang L
Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
[TBL] [Abstract][Full Text] [Related]
6. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
Ramezani Tehrani F; Minooee S; Azizi F
Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.
Başar Gökcen B; Akdevelioğlu Y; Canan S; Bozkurt N
Eat Weight Disord; 2021 Jun; 26(5):1581-1593. PubMed ID: 32772321
[TBL] [Abstract][Full Text] [Related]
8. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study.
Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N
J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
10. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
Kałużna M; Czlapka-Matyasik M; Kompf P; Moczko J; Wachowiak-Ochmańska K; Janicki A; Samarzewska K; Ruchała M; Ziemnicka K
Ther Adv Endocrinol Metab; 2022; 13():20420188211066699. PubMed ID: 35035875
[TBL] [Abstract][Full Text] [Related]
11. Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.
Banu H; Morshed MS; Sultana T; Shah S; Afrine S; Hasanat MA
J Hum Reprod Sci; 2022; 15(1):27-33. PubMed ID: 35494190
[TBL] [Abstract][Full Text] [Related]
12. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
[No Abstract] [Full Text] [Related]
13. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
14. Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.
Techatraisak K; Wongmeerit K; Dangrat C; Wongwananuruk T; Indhavivadhana S
Gynecol Endocrinol; 2016; 32(4):276-80. PubMed ID: 26503544
[TBL] [Abstract][Full Text] [Related]
15. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
16. Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome.
Kulik-Kupka K; Jabczyk M; Nowak J; Jagielski P; Hudzik B; Zubelewicz-Szkodzińska B
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235688
[TBL] [Abstract][Full Text] [Related]
17. The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?
Apaydin M; Kazan ED; Beysel S; Sari A; Özgül E; Cengiz H; Demirci T; Yilmazer M
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7182-7187. PubMed ID: 36263527
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profile in women with polycystic ovary syndrome across adult life.
Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
[TBL] [Abstract][Full Text] [Related]
19. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients.
Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A
Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690
[No Abstract] [Full Text] [Related]
20. Characteristics of Different Obesity Metabolic Indexes and their Correlation with Insulin Resistance in Patients with Polycystic Ovary Syndrome.
Feng Y; Li M; Li X; Tang Q; Li X; Ji X; Tian W; Zhang H
Reprod Sci; 2024 Apr; ():. PubMed ID: 38649666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
